Syren Pharmaceuticals Ltd., Isis Innovation Ltd. deal

Syren acquired an option from Isis, the technology transfer arm of the University of Oxford (Oxford, U.K.), to license a group of terpyridine platinum-based cancer compounds developed at the universit...